France: Sofinnova Partners closes medtech acceleration fund at €63m

Sofinnova Partners, a European venture capital firm in life sciences, specialising in healthcare and sustainability, has announced the final close of its medtech acceleration fund, Sofinnova MD Start III, at €63m (US$74.5m). The fund was oversubscribed and exceeded its original target, according to Sofinnova, with new investors joining existing investors. Sofinnova MD Start’s team is…